Status: Recruiting
Visual and Patient Reported Outcomes With Clareon TruPlus
This is a prospective, single-site, two-surgeon, single-arm, observational study evaluating the Clareon TruPlus IOL. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the IOLSAT Questionnaire.
Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: OVO LASIK + LensUpdated: Jun 15, 2026Locations: 1
Eligibility criteria
Willing and able to understand and sign informed consent. [+2]
Subjects targeted for monovision. [+5]